MedPath

Comparison of fentanyl and midazolam in spinal anaesthesia in lower segment caesarean section patients

Phase 2
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2023/11/059618
Lead Sponsor
Acharya Vinobha Bhave Rural Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age between 18 to 35years

2. Patients undergoing cesarean section

3. Primi gravida with gestational age more than 37 weeks

4. Body mass index 20 to 29.9kg/meter square

5. Intact amniotic membrane

6. No history of bleeding tendency or coagulopathies or with any neuromuscular disorders or neurological diseases.

7. No previous uterine operations except cesarean sections

8. Living fetus

9. ASA II

10. Patients giving informed consent.

Exclusion Criteria

1. Patients who are multigravida, previous LSCS.

2. ASA CLASS 3 AND CLASS 4.

3. Patients refusal.

4. Patients with any co-morbities.

5. Patients with infection at the site of injection.

6. Patients with sensitivity to local anaesthetic agent, fentanyl and midazolam.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare and to evaluate efficacy of intrathecal Fentanyl and intrathecal Midazolam added as adjuvant to Bupivacaine 0.5% (heavy) in patients undergoing lower segment caesarean sectionTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Compare the effect of fentanyl & midazolam on <br/ ><br>intraoperative haemodynamics <br/ ><br>The Onset & Duration of Sensory And Motor Block <br/ ><br>To compare the role of fentanyl and midazolam as an adjuvant <br/ ><br>for prevention of side effects <br/ ><br>To access APGAR score <br/ ><br>Timepoint: 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath